|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:healthcare_organization
|
|
gptkbp:caused_by
|
gptkb:healthcare_organization
|
|
gptkbp:current_use
|
gptkb:hepatocellular_carcinoma
|
|
gptkbp:discovered_by
|
gptkb:1967
|
|
gptkbp:disease_resistance
|
liver cancer
cirrhosis
|
|
gptkbp:duration
|
long-term
|
|
gptkbp:family
|
gptkb:Hepadnaviridae
|
|
gptkbp:genus
|
gptkb:Orthohepadnavirus
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
hepatitis B virus
|
|
gptkbp:incubation_period
|
30 to 180 days
|
|
gptkbp:is_adopted_by
|
possible treatment option
|
|
gptkbp:is_popular_in
|
high
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_tested_for
|
used for monitoring
|
|
gptkbp:is_vulnerable_to
|
gptkb:battle
|
|
gptkbp:metabolism
|
used for assessment
|
|
gptkbp:research_focus
|
immune response
vaccine development
viral replication
antiviral therapy
|
|
gptkbp:risk_factor
|
sharing needles
unprotected sex
exposure to infected blood
mother with hepatitis B
|
|
gptkbp:scientific_classification
|
gptkb:Group_1_carcinogen
|
|
gptkbp:seed_dispersal
|
partially double-stranded DNA
|
|
gptkbp:social_responsibility
|
gptkb:HCV
gptkb:HIV
possible
blood test
HDV
10% to 15% of adults
90% of infants
endemic in Africa
endemic in Asia
endemic in Eastern Europe
endemic in the Middle East
endemic in the Pacific Islands
|
|
gptkbp:symptoms
|
fatigue
nausea
abdominal pain
jaundice
loss of appetite
|
|
gptkbp:transmission
|
gptkb:healthcare_organization
sexual contact
mother to child
|
|
gptkbp:treatment
|
gptkb:drug
regular monitoring
viral suppression
|
|
gptkbp:was_marked_by
|
H Bs Ag
anti-H Bc
anti-H Bs
|